Top Markets
#1 Decred Decred +10.19%
#2 Wibx Wibx +9.06%
#3 Status Status +7.37%
#4 aelf aelf +5.49%
#5 SkyAI SkyAI +4.75%
#6 MarsCoin MarsCoin +4.32%
#7 Rei Rei +4.03%
#8 Robinhood Wrapped ETH (Robinhood Chain) Robinhood Wrapped ETH (Robinhood Chain) +3.86%
#9 TRIA TRIA +3.71%
#10 Humanity Humanity +3.23%
Coin of the day
Decred Decred
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Kedudukan dalam Saham #30680
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Harga Saham
$0.91968646
Disegerakkan terakhir: 2026-08-18
Modal Pasaran
$15.91M
Perubahan (1 hari)
2.23%
Perubahan (1 tahun)
-52.75%
Negara
KR
Perdagangan Xcell Therapeutics, Inc. (373110)

Kategori

Healthcare
Sejarah hasil dividen untuk Xcell Therapeutics, Inc. (373110)
Hasil dividen (TTM) bagi Xcell Therapeutics, Inc. (simbol saham: 373110) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Xcell Therapeutics, Inc. (373110) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE